Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ANTARES PHARMA
(NQ:
ATRS
)
4.060
USD
+0.080 (+2.01%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about ANTARES PHARMA
< Previous
1
2
3
4
5
6
Next >
Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference
May 09, 2013
from
Business Wire News Releases
Antares Pharma Reports First Quarter 2013 Operating and Financial Results
May 08, 2013
from
Business Wire News Releases
Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call
May 01, 2013
from
Business Wire News Releases
Antares Pharma Announces the Issuance of a New Patent on VIBEX™ Device Platform
April 16, 2013
from
Business Wire News Releases
Pre-Market Analysis on Life Technologies, Quest Diagnostics, Brookdale Senior Living, Antares Pharma, and Optimer Pharma
April 12, 2013
from
PR Newswire
Antares Pharma Announces Notice of Allowance for New Patent on VIBEX™ QuickShot Device
April 05, 2013
from
Business Wire News Releases
Antares Pharma Announces First Shipment of Commercial VIBEX™ Auto-Injector Devices to Teva
April 03, 2013
from
Business Wire News Releases
Antares Pharma Reports Fourth Quarter and Full Year 2012 Operating and Financial Results
March 13, 2013
from
Business Wire News Releases
Today's Technical View on Covidien, Becton, Dickinson and Co., Antares Pharma, and DENTSPLY Intl.
March 06, 2013
from
PR Newswire
Antares Pharma to Host Fourth Quarter 2012 Call
March 06, 2013
from
Business Wire News Releases
Antares Pharma Announces FDA Acceptance of New Drug Application for OTREXUP™
February 27, 2013
from
Business Wire News Releases
Antares Pharma to Present at the Cowen and Company 33rd Annual Healthcare Conference
February 26, 2013
from
Business Wire News Releases
Antares Pharma to Participate in the 2013 RBC Capital Markets’ Healthcare Conference
February 20, 2013
from
Business Wire News Releases
Free Research Report on Abercrombie & Fitch Co., Anadarko Petroleum Corp., Ashland, Inc., Athersys, Inc. and Antares Pharma, Inc.
January 31, 2013
from
PR Newswire
Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013
January 24, 2013
Five Star Equities Provides Stock Research on Antares Pharma and Celldex Therapeutics
Read More
from
Marketwired News Releases
Antares Pharma Announces Submission of New Drug Application for OTREXUP™
December 17, 2012
from
Business Wire News Releases
Antares Pharma to Present at the Oppenheimer 23rd Annual Healthcare Conference
December 05, 2012
from
Business Wire News Releases
Antares Pharma Announces Positive Results from Final MTX Medi-Jet™ Clinical Study
November 13, 2012
from
Business Wire News Releases
Antares Pharma to Present at the Jefferies 2012 Global Healthcare Conference
November 08, 2012
from
Business Wire News Releases
Antares Pharma Reports Third Quarter 2012 Financial and Operating Results
November 07, 2012
from
Business Wire News Releases
Antares Pharma to Host Third Quarter 2012 Earnings Call
November 02, 2012
from
Business Wire News Releases
Antares Pharma Announces Closing of Public Offering of Common Stock
October 09, 2012
from
Business Wire News Releases
Antares Pharma Announces Pricing of Public Offering of Common Stock
October 03, 2012
from
Business Wire News Releases
Antares Pharma Announces Proposed Public Offering of Common Stock
October 02, 2012
from
Business Wire News Releases
Antares Pharma Receives Development Milestone Payment
October 02, 2012
from
Business Wire News Releases
Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study
September 25, 2012
from
Business Wire News Releases
Recent Deal to Help Speed Up FDA Review Process Could Be in Jeopardy
September 12, 2012
Five Star Equities Provides Stock Research on Antares Pharma and Sunshine Heart
Read More
from
Marketwired News Releases
Antares Pharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
August 30, 2012
from
Business Wire News Releases
Antares Pharma Reports Second Quarter 2012 Financial and Operating Results
August 08, 2012
from
Business Wire News Releases
Antares Pharma to Host Second Quarter 2012 Earnings Call
August 01, 2012
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here